Peptide World
EN
← Research Library
Cognition · 5 min read Evidence: Animal

Pinealon: sleep and cognition claims still rest on a thin English-language record

This short Khavinson-associated peptide is marketed for brain aging. Independent randomized trials remain scarce.

Pinealon is a short synthetic peptide associated with the same bioregulator tradition as epitalon. Marketing copy links it to sleep, memory and “brain protection.”

What you can find

A PubMed search returns a small set of experimental papers, often from overlapping author groups, frequently in cell or animal systems. English-language randomized, independently replicated human trials with prespecified sleep or cognition endpoints are not the core of that record.

How to treat the category

Pineal and “bioregulator” peptides are easy to bundle. Extracts (such as epithalamin) and defined synthetics (epitalon, pinealon) are not interchangeable, and a Russian registration is not an FDA approval.

Bottom line

Evidence ladder: Animal / limited human reports. Sleep and cognition are easy to claim and hard to prove. Demand controlled trials.

Sources

  1. PubMed u2014 pinealon ↗
  2. Overview of Epitalon. Int J Mol Sci 2025 (pineal peptide context) ↗

Questions about this article? The AI Scholar can walk you through the studies.

Educational content only — not medical advice. See our Medical disclaimer and Editorial policy.

Keep reading